A research team has, for the first time in the world, revealed the identity and differentiation process of human cervical stem cells. The results showed that lactic acid bacteria can inhibit the ...
Through strategic gene-editing, researchers have overcome one of the main roadblocks of iPSC-derived rejuvenated T lymphocytes in cervical cancer therapy. Cervical cancer is among the most common ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results